Literature DB >> 21748781

Therapeutic factors secreted by mesenchymal stromal cells and tissue repair.

Ryang Hwa Lee1, Joo Youn Oh, Hosoon Choi, Nikolay Bazhanov.   

Abstract

Systemic administration of MSCs resulted in remarkable functional improvements in injured tissues without either long-term engraftment or differentiation in many clinical and experimental situations. Emerging evidence suggest that most of the beneficial effects of MSCs could be explained by secretion of soluble factors that have multiple effects including modulation of inflammatory and immune reactions, protection from cell death, and stimulation of endogenous progenitor cells. In this review, we focus on the therapeutic factors that account for the beneficial effects of MSCs in animal models of human diseases.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21748781     DOI: 10.1002/jcb.23250

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  41 in total

Review 1.  Engineering stem cell niches in bioreactors.

Authors:  Meimei Liu; Ning Liu; Ru Zang; Yan Li; Shang-Tian Yang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

2.  Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response.

Authors:  Joo Youn Oh; Ryang Hwa Lee; Ji Min Yu; Jung Hwa Ko; Hyun Ju Lee; Ah Young Ko; Gavin W Roddy; Darwin J Prockop
Journal:  Mol Ther       Date:  2012-08-28       Impact factor: 11.454

3.  The microenvironment of embryoid bodies modulated the commitment to neural lineage postcryopreservation.

Authors:  Sébastien Sart; Yuanwei Yan; Yan Li
Journal:  Tissue Eng Part C Methods       Date:  2014-10-09       Impact factor: 3.056

4.  Isolation, culture and chondrogenic differentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells--a comparative study.

Authors:  Christine M Reich; Oksana Raabe; Sabine Wenisch; Philip S Bridger; Martin Kramer; Stefan Arnhold
Journal:  Vet Res Commun       Date:  2012-03-04       Impact factor: 2.459

5.  TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.

Authors:  Ryang Hwa Lee; Ji Min Yu; Andrea M Foskett; Grant Peltier; John C Reneau; Nikolay Bazhanov; Joo Youn Oh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

6.  REVERSAL OF FIBRONECTIN-INDUCED HIPPOCAMPAL DEGENERATION WITH ENCAPSULATED MESENCHYMAL STROMAL CELLS.

Authors:  Jean-Pierre Dollé; Jeffrey Barminko; Sai Veruva; Casey Moure; Rene Schloss; Martin L Yarmush
Journal:  Nano Life       Date:  2013-12

7.  The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment.

Authors:  Mrinal K Das; Taral R Lunavat; Hrvoje Miletic; Jubayer A Hossain
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior.

Authors:  Matthew M Piaseczny; Graciella M Pio; Jenny E Chu; Ying Xia; Kim Nguyen; David Goodale; Alison Allan
Journal:  J Vis Exp       Date:  2016-06-13       Impact factor: 1.355

Review 9.  Human oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells.

Authors:  Q Z Zhang; A L Nguyen; W H Yu; A D Le
Journal:  J Dent Res       Date:  2012-09-17       Impact factor: 6.116

Review 10.  Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

Authors:  Joo Youn Oh; Ryang Hwa Lee
Journal:  Prog Retin Eye Res       Date:  2021-03-26       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.